Scientists are closing in on something the medical world has been searching for for decades: a way to treat chronic pain as effectively as opioids, without the addiction, overdose risk, or mind-altering effects that make opioids so dangerous. Two separate research teams have recently made significant progress toward that goal using compounds derived from the cannabis plant, neither of which contains THC, the psychoactive ingredient responsible for a high. Researchers at the University of Arizona found that terpenes, naturally occurring aromatic compounds found in cannabis, produced significant reductions in chronic pain in preclinical models of both fibromyalgia and post-surgical pain, and did so more effectively than opioids in the conditions tested. The findings were the first to specifically examine terpenes in those two pain contexts, and the lead researcher called them a potentially viable treatment for fibromyalgia, a condition that currently has few good options and affects millions of people.
In a separate line of research, scientists at Washington University School of Medicine and Stanford University designed a custom synthetic compound modeled on a natural cannabis molecule, engineered so that it activates pain-reducing receptors throughout the body but is physically unable to cross into the brain. That design is what makes it so promising: by staying outside the brain, the compound bypasses the reward pathways that make opioids addictive and eliminates the psychoactive effects entirely, while still providing meaningful pain relief in animal models with almost no tolerance buildup over time. The researchers said designing a molecule that relieves pain with minimal side effects is one of the hardest challenges in pharmacology, and this one clears multiple hurdles at once. Neither approach has yet entered human clinical trials, but scientists in both teams said the path forward is clearer than it has ever been.
